Literature DB >> 1009925

Human-serum cholinesterase subunits and number of active sites of the major component.

H Muensch, H W Goedde, A Yoshida.   

Abstract

The major C4 component of human serum cholinesterase was highly purified by a two-step procedure involving chromatography on DEAE-cellulose and preparative disc electrophoresis. The final product was about 8 000-fold purified with a yield of 64%. The subunit structure was determined by 8M urea polyacrylamide disc electrophoresis and by the sedimentation equilibrium centrifugation method in 5M guanidine hydrochloride. It was found that the C4 enzyme has a tetrameric structure. The subunits are equal in size and charge and a molecular weight comparable to that of the C1 enzyme from native serum. The major C4 enzyme and the minor C1 enzyme were subjected to an 'active enzyme centrifugation'. It was found that the C4 enzyme was a tetramer and the C1 enzyme was a monomer in the presence of substrate. The number of diisopropylphosphofluoridate-binding sites was measured from the molar ratio of bound diisopropylphosphate to protein. A value close to two binding sites was found for the C4 enzyme.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1009925     DOI: 10.1111/j.1432-1033.1976.tb10972.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine.

Authors:  Max Zhan; Shurong Hou; Chang-Guo Zhan; Fang Zheng
Journal:  Biochem J       Date:  2014-01-01       Impact factor: 3.857

2.  A case of familial hyper-cholinesterasemia associated with isozyme variant band.

Authors:  K Yamamoto; F Morito; M Motomura; H Kaneoka; T Sakai
Journal:  Gastroenterol Jpn       Date:  1986-08

3.  Aluminum inhibition of human serum cholinesterase.

Authors:  J K Marquis
Journal:  Bull Environ Contam Toxicol       Date:  1983-08       Impact factor: 2.151

4.  Use of procainamide gels in the purification of human and horse serum cholinesterases.

Authors:  J S Ralston; A R Main; B F Kilpatrick; A L Chasson
Journal:  Biochem J       Date:  1983-04-01       Impact factor: 3.857

5.  Characterization of serum cholinesterase in familial hyper-cholinesterasemia associated with an isozyme variant band.

Authors:  K Yamamoto; F Morito; Y Setoguchi; S Fujii; T Kariya; T Sakai
Journal:  Gastroenterol Jpn       Date:  1987-04

6.  Structural difference at the active site of dibucaine resistant variant of human plasma cholinesterase.

Authors:  H Muensch; A Yoshida; K Altland; W Jensen; H W Goedde
Journal:  Am J Hum Genet       Date:  1978-05       Impact factor: 11.025

7.  A study of the cholinesterases of the canine pancreatic sphincters and the relationship between reduced butyrylcholinesterase activity and pancreatic ductal hypertension.

Authors:  T D Dressel; R L Goodale; J W Borner; S Etani
Journal:  Ann Surg       Date:  1980-11       Impact factor: 12.969

8.  Amino acid sequence of the active site of human pseudocholinesterase.

Authors:  K Yamato; I Y Huang; H Muensch; A Yoshida; H W Goedde; D P Agarwal
Journal:  Biochem Genet       Date:  1983-02       Impact factor: 1.890

9.  Properties of acetylcholinesterase and non-specific cholinesterase in rat superior cervical ganglion and plasma.

Authors:  B Klinar; L Kamarić; J Sketelj; M Brzin
Journal:  Neurochem Res       Date:  1985-06       Impact factor: 3.996

10.  Tuning Butyrylcholinesterase Inactivation and Reactivation by Polymer-Based Protein Engineering.

Authors:  Libin Zhang; Stefanie L Baker; Hironobu Murata; Nicholas Harris; Weihang Ji; Gabriel Amitai; Krzysztof Matyjaszewski; Alan J Russell
Journal:  Adv Sci (Weinh)       Date:  2019-11-13       Impact factor: 16.806

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.